cyclopentane has been researched along with angiogenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardelt, W; D'Alessio, G; De Lorenzo, C; Gadina, M; Mikulski, SM; Saxena, SK; Wu, Y; Youle, RJ | 1 |
| Arakawa, M; Ikeda, D; Kawada, M; Someno, T | 1 |
| Hassan, NM; Hu, GF; Ibaragi, S; Kishimoto, K; Mandai, H; Okui, T; Omori, K; Sasaki, A; Shibata, A; Shimo, T; Suga, S; Takashiba, S; Tsumura, T | 1 |
3 other study(ies) available for cyclopentane and angiogenin
| Article | Year |
|---|---|
A study of the intracellular routing of cytotoxic ribonucleases.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Brefeldin A; Cattle; Cell Survival; Cyclopentanes; Egg Proteins; Golgi Apparatus; Humans; Molecular Sequence Data; Monensin; Proteins; Rats; Ribonuclease, Pancreatic; Ribonucleases; RNA; Tretinoin; Tumor Cells, Cultured | 1995 |
A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis.
Topics: Antineoplastic Agents; Aspergillus; Cell Line, Tumor; Culture Media; Cyclopentanes; Endothelial Cells; Glucosides; Humans; Inhibitory Concentration 50; Ribonuclease, Pancreatic | 2008 |
Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Disease Progression; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Ribonuclease, Pancreatic | 2016 |